Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions

Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?

(2022) Caitlin R. Semsarian et al.   BRITISH JOURNAL OF DERMATOLOGY

Towards diagnostic criteria for malignant deep penetrating melanocytic tumors using single nucleotide polymorphism array and next-generation sequencing

(2022) Chiel F. Ebbelaar et al.   MODERN PATHOLOGY

The Rapid Rise in Cutaneous Melanoma Diagnoses

(2021) H. Gilbert Welch et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estimating the potential impact of interventions to reduce over‐calling and under‐calling of melanoma

(2021) M Gibson et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Genome-wide copy number variations as molecular diagnostic tool for cutaneous intermediate melanocytic lesions: a systematic review and individual patient data meta-analysis

(2021) Chiel F. Ebbelaar et al.   VIRCHOWS ARCHIV

Melanoma pathology: new approaches and classification*

(2021) I. Yeh et al.   BRITISH JOURNAL OF DERMATOLOGY

Assessment of a Diagnostic Classification System for Management of Lesions to Exclude Melanoma

(2021) Ian Katz et al.   JAMA Network Open

The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway

(2020) David E. Elder et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution

(2020) Teo Soleymani et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Outcomes of surgical re-excision versus observation of severely dysplastic nevi: a single institution, retrospective cohort study

(2019) Nathaniel H. Fleming et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors

(2018) Serigne N. Lo et al.   ANNALS OF SURGICAL ONCOLOGY

Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins

(2018) Caroline C. Kim et al.   JAMA Dermatology

Recurrence of moderately dysplastic nevi with positive histologic margins

(2017) Bryan Hiscox et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study

(2017) Joann G Elmore et al.   BMJ-British Medical Journal

Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study

(2017) Joann G Elmore et al.   BMJ-British Medical Journal

Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi

(2016) Nathaniel H. Fleming et al.   JAMA Dermatology

The Genetic Evolution of Melanoma from Precursor Lesions

(2015) A. Hunter Shain et al.   NEW ENGLAND JOURNAL OF MEDICINE

TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms

(2015) Seungjae Lee et al.   Scientific Reports

Histomorphologic Assessment and Interobserver Diagnostic Reproducibility of Atypical Spitzoid Melanocytic Neoplasms With Long-term Follow-up

(2014) Pedram Gerami et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Diameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: A case-control study

(2014) Michael Y. Xiong et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The MPATH-Dx reporting schema for melanocytic proliferations and melanoma

(2013) Michael W. Piepkorn et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The melanoma ‘epidemic’: lessons from prostate cancer

(2011) Earl J. Glusac   JOURNAL OF CUTANEOUS PATHOLOGY

Increased diagnosis of thin superficial spreading melanomas: A 20-year study

(2011) Jason E. Frangos et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin

(2011) David C. Whiteman et al.   Pigment Cell & Melanoma Research

Atypical Cellular Blue Nevi (Cellular Blue Nevi With Atypical Features): Lack of Consensus for Diagnosis and Distinction From Cellular Blue Nevi and Malignant Melanoma (“Malignant Blue Nevus”)

(2009) Raymond L. Barnhill et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY